Lifecore Biomedical Inc. logo

Lifecore Biomedical Inc.

LFCR | NASDAQ
Chart Builder DCF Calculator
$4.47
-$0.01 (-0.22%)
Sep 22, 2026, 11:48 AM ET · Market open

Company Profile

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Key Executives

Name Position
Paul Josephs President, Chief Executive Officer & Director
Ryan D. Lake Executive Vice President & Chief Financial Officer
Aaron Perlitsh Director of Internal Audit & Chief Compliance Officer
Jackie Q. Klecker Executive Vice President of Quality & Development Services
Mark DaFonseca Chief Commercial Officer
Parker K. Javid Vice President
Thomas Guldager Senior Vice President of Operations
Thomas Salus Chief Legal and Administration Officer & Corporate Secretary

Latest SEC Filings

Date Type Title
Aug 05, 2026 10-Q Quarterly Report
Aug 05, 2026 8-K Current Report
Jul 29, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Jul 02, 2026 SC 13D/A [Amend] Filing
Jul 02, 2026 8-K Current Report
Jul 02, 2026 SC 13D/A [Amend] Filing
Jun 08, 2026 4 Filing
Jun 05, 2026 4 Filing
Jun 05, 2026 4 Filing
Jun 05, 2026 4 Filing
View All SEC Filings
Lifecore Biomedical Inc.
Lifecore Biomedical Inc. logo
Country United States
IPO Date Feb 14, 1996
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 382
CEO Paul Josephs

Contact Details

3515 Lyman Boulevard Chaska, Minnesota 55318 United States

Stock Details

Ticker Symbol LFCR
Exchange NASDAQ
Fiscal Year June - May
Reporting Currency USD
CIK Code 0001005286
CUSIP Number 514766104
ISIN Number US5147661046
SIC Code 2834

© 2026 bestshares.com. All rights reserved.